Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dawn Merbach"'
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 11, Pp 2904-2911 (2024)
Abstract Objective Strokes involving sensory pathways can result in contralesional pain syndromes often refractory to pharmacologic interventions. Scrambler therapy (ST) is a noninvasive electroanalgesia device used to treat pain caused by peripheral
Externí odkaz:
https://doaj.org/article/4417e0047c8648aeb3f49e61e7d15769
Publikováno v:
Stroke. 50
Introduction: After treatment with intravenous tissue plasminogen activator (IV tPA) or intra-arterial thrombolysis (IA lysis) patients are monitored intensely for evidence of change in neurological examination and possible intracranial hemorrhage (I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b83b7621de4c5ab04781771479c05fe3
https://doi.org/10.1161/str.50.suppl_1.wp429
https://doi.org/10.1161/str.50.suppl_1.wp429
Publikováno v:
The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. 50(1)
Background For ischemic stroke, the chance of improved recovery is directly impacted by length of time from symptom onset to administration of intravenous tissue plasminogen activator (IV tPA). Despite the importance of rapid treatment, stroke center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b01dfd4975989a097ac26b5e92d653f
https://pubmed.ncbi.nlm.nih.gov/29303837
https://pubmed.ncbi.nlm.nih.gov/29303837
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 28:104278
Prior studies have shown that warfarin is effective for both primary and secondary stroke prevention in individuals with atrial fibrillation. It is also known that those on warfarin with atrial fibrillation often have poorer long-term poststroke outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ba121de4ef28eaf7cf2fcce9e48f61
https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.06.036
https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.06.036
Autor:
Stowell‐Campos, Robert1 (AUTHOR), Lawrence, Erin1 (AUTHOR), Marsh, Elisabeth Breese1 (AUTHOR), Merbach, Dawn1 (AUTHOR) dmerbac1@jhmi.edu
Publikováno v:
Annals of Clinical & Translational Neurology. Nov2024, Vol. 11 Issue 11, p2904-2911. 8p.
Publikováno v:
Stroke. 46
Background: For acute ischemic stroke, the chance of improved recovery is directly impacted by the length of time from symptom onset to administration of intravenous tissue plasminogen activator (IV t-PA). Despite the importance of rapid treatment, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12963d70f99a698ed932e6b9a17e385f
https://doi.org/10.1161/str.46.suppl_1.tp338
https://doi.org/10.1161/str.46.suppl_1.tp338
Autor:
Erin Lawrence, Cheryl Woolford, Dawn Merbach, Sherry Thorpe, Rafael H Llinas, Elisabeth B Marsh
Publikováno v:
Stroke. 46
Background: The Electronic Medical Record (EMR) was designed to improve patient outcomes, eliminate unnecessary costs, and provide continuity of care. Intravenous tissue plasminogen activator (IV t-PA) is most effective when administered early. In or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::922812d9f61b96ec8437a98db3902def
https://doi.org/10.1161/str.46.suppl_1.tp340
https://doi.org/10.1161/str.46.suppl_1.tp340
Autor:
Marsh, Elisabeth B.1 (AUTHOR) ebmarsh@jhmi.edu, Khan, Sheena1 (AUTHOR), Llinas, Rafael H.1 (AUTHOR), Walker, Keenan A.2 (AUTHOR), Brandt, Jason1,3 (AUTHOR)
Publikováno v:
Brain & Behavior. May2022, Vol. 12 Issue 5, p1-11. 11p.
Publikováno v:
Pain & Central Nervous System Week; 10/21/2024, p770-770, 1p